Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
86.56m
Last Price
$2.69
52-Week Range
$2.145 - $5.13
12/20/2024 09:00 PM EST
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808